The saccadic and neurological deficits in type 3 Gaucher disease
William Benko, Markus Ries, Edythe A Wiggs, Roscoe O Brady, Raphael Schiffmann, Edmond J Fitzgibbon, William Benko, Markus Ries, Edythe A Wiggs, Roscoe O Brady, Raphael Schiffmann, Edmond J Fitzgibbon
Abstract
Our objective was to characterize the saccadic eye movements in patients with type 3 Gaucher disease (chronic neuronopathic) in relationship to neurological and neurophysiological abnormalities. For approximately 4 years, we prospectively followed a cohort of 15 patients with Gaucher type 3, ages 8-28 years, by measuring saccadic eye movements using the scleral search coil method. We found that patients with type 3 Gaucher disease had a significantly higher regression slope of duration vs amplitude and peak duration vs amplitude compared to healthy controls for both horizontal and vertical saccades. Saccadic latency was significantly increased for horizontal saccades only. Downward saccades were more affected than upward saccades. Saccade abnormalities increased over time in some patients reflecting the slowly progressive nature of the disease. Phase plane plots showed individually characteristic patterns of abnormal saccade trajectories. Oculo-manual dexterity scores on the Purdue Pegboard test were low in virtually all patients, even in those with normal cognitive function. Vertical saccade peak duration vs amplitude slope significantly correlated with IQ and with the performance on the Purdue Pegboard but not with the brainstem and somatosensory evoked potentials. We conclude that, in patients with Gaucher disease type 3, saccadic eye movements and oculo-manual dexterity are representative neurological functions for longitudinal studies and can probably be used as endpoints for therapeutic clinical trials.
Trial registration: ClinicalTrials.gov NCT00001289.
Conflict of interest statement
Competing Interests: Research grants and honoraria from Genzyme Corporation, Shire HGT and Amicus Therapeutics.
Figures
References
- Brady RO, Kanfer JN, Bradley RM, Shapiro D. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest. 1966;45:1112–1115.
- Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, et al. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab. 2004;82:192–207.
- Schiffmann R, Vellodi A. Neuronopathic Gaucher Disease. In: Futerman AH, Zimran A, editors. Gaucher disease. Boca Raton Florida: CRC Press Taylor & Francis; 2007. pp. 175–196.
- Enquist IB, Lo Bianco C, Ooka A, Nilsson E, Mansson JE, et al. Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci U S A. 2007;104:17483–17488.
- Garbutt S, Harwood MR, Harris CM. Comparison of the main sequence of reflexive saccades and the quick phases of optokinetic nystagmus. Br J Ophthalmol. 2001;85:1477–1483.
- Harris CM, Taylor DS, Vellodi A. Ocular motor abnormalities in Gaucher disease. Neuropediatrics. 1999;30:289–293.
- Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, et al. Randomized, controlled trial of miglustat in Gaucher's disease type 3. Ann Neurol. 2008;64:514–522.
- Garbutt S, Harris CM. Abnormal vertical optokinetic nystagmus in infants and children. Br J Ophthalmol. 2000;84:451–455.
- Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, et al. Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis. 2009;32:660–664.
- Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neurosciences. Brain. 2004;127:460–477.
- Saavedra S, Joshi A, Woollacott M, van Donkelaar P. Eye hand coordination in children with cerebral palsy. Exp Brain Res. 2009;192:155–165.
- Myung JY, Blumstein SE, Yee E, Sedivy JC, Thompson-Schill SL, et al. Impaired access to manipulation features in Apraxia: evidence from eyetracking and semantic judgment tasks. Brain Lang. 2010;112:101–112.
- Sacrey LA, Travis SG, Whishaw IQ. Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task. Behav Brain Res. 2011;217:391–398.
- Rand MK, Stelmach GE. Effects of hand termination and accuracy requirements on eye-hand coordination in older adults. Behav Brain Res. 2011;219:39–46.
- Garvey MA, Toro C, Goldstein S, Altarescu G, Wiggs EA, et al. Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease. Neurology. 2001;56:391–394.
- Campbell PE, Harris CM, Vellodi A. Deterioration of the auditory brainstem response in children with type 3 Gaucher disease. Neurology. 2004;63:385–387.
- Lacey DJ, Terplan K. Correlating auditory evoked and brainstem histologic abnormalities in infantile Gaucher's disease. Neurology. 1984;34:539–541.
- Inchingolo P, Spanio M. On the identification and analysis of saccadic eye movements--a quantitative study of the processing procedures. IEEE Trans Biomed Eng. 1985;32:683–695.
- Hays AV, Richmond BJ, Optican LM. A UNIX-based multiple process system for real-time data acquisition and control. WESCON Conference Proceedings. 1982;2:1–10.
- Inchingolo P, Spanio M, Bianchi M. The characteristics peak velocity - mean velocity of saccadic eye movements in man. In: O'Regan JK, Levy-Shoen A, editors. Eye movements: from physiology to cognition. Amsterdam: Elsevier Science Publishers; 1987. pp. 17–26.
- Altarescu G, Hill S, Wiggs E, Jeffries N, Kreps C, et al. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. J Pediatr. 2001;138:539–547.
- Yeudall LT, Fromm D, Reddon JR, Stefanyk WO. Normative data streatified by age and sex for 12 neuropsychological tests Journal of Clinical Psychology. 1986;42:918–946.
- Gardner RA, Broman M. The Purdue Pegbord: Normative data on 1334 school children. Journal of Clinical Child Psychology. 1979;8:156–162.
- Bhidayasiri R, Riley DE, Somers JT, Lerner AJ, Buttner-Ennever JA, et al. Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology. 2001;57:2070–2077.
- Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605–613.
- Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med. 1989;8:431–440.
- Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6:765–772.
- Reyes-Puerta V, Philipp R, Lindner W, Hoffmann KP. Role of the rostral superior colliculus in gaze anchoring during reach movements. J Neurophysiol. 2010;103:3153–3166.
- Nummela SU, Krauzlis RJ. Inactivation of primate superior colliculus biases target choice for smooth pursuit, saccades, and button press responses. J Neurophysiol. 2010;104:1538–1548.
Source: PubMed